The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world study

被引：0
|
作者：
Jinbin Chen
Peiyao Xiong
Man Nie
Yangxun Pan
Juncheng Wang
Dandan Hu
Zhongguo Zhou
Yaojun Zhang
Minshan Chen
Li Xu
机构：
[1] Sun Yat-Sen University Cancer Center,State Key Laboratory of Oncology in South China
[2] Collaborative Innovation Center for Cancer Medicine,Department of Liver Surgery
[3] Sun Yat-Sen University Cancer Center,Department of Medical Oncology
[4] Sun Yat-Sen University Cancer Center,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Hepatocellular carcinoma; Lenvatinib; Local therapy; PD-1/PD-L1 inhibitor; Combination therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2491 / 2500
页数：9
相关论文
共 50 条
  • [1] The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world study
    Chen, Jinbin
    Xiong, Peiyao
    Nie, Man
    Pan, Yangxun
    Wang, Juncheng
    Hu, Dandan
    Zhou, Zhongguo
    Zhang, Yaojun
    Chen, Minshan
    Xu, Li
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (06) : 2491 - 2500
  • [2] Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study
    Kurvi Patwala
    David Stephen Prince
    Yael Celermajer
    Waafiqa Alam
    Eldho Paul
    Simone Irene Strasser
    Geoffrey William McCaughan
    Paul Gow
    Siddharth Sood
    Elise Murphy
    Stuart Roberts
    Elliot Freeman
    Elizabeth Stratton
    Scott Anthony Davison
    Miriam Tania Levy
    McCawley Clark-Dickson
    Vi Nguyen
    Sally Bell
    Amanda Nicoll
    Ashley Bloom
    Alice Unah Lee
    Marno Ryan
    Jessica Howell
    Zina Valaydon
    Alexandra Mack
    Ken Liu
    Anouk Dev
    [J]. Hepatology International, 2022, 16 : 1170 - 1178
  • [3] Lenvatinib for the treatment of hepatocellular carcinoma-a real-world multicenter Australian cohort study
    Patwala, Kurvi
    Prince, David Stephen
    Celermajer, Yael
    Alam, Waafiqa
    Paul, Eldho
    Strasser, Simone Irene
    McCaughan, Geoffrey William
    Gow, Paul
    Sood, Siddharth
    Murphy, Elise
    Roberts, Stuart
    Freeman, Elliot
    Stratton, Elizabeth
    Davison, Scott Anthony
    Levy, Miriam Tania
    Clark-Dickson, Mccawley
    Vi Nguyen
    Bell, Sally
    Nicoll, Amanda
    Bloom, Ashley
    Lee, Alice Unah
    Ryan, Marno
    Howell, Jessica
    Valaydon, Zina
    Mack, Alexandra
    Liu, Ken
    Dev, Anouk
    [J]. HEPATOLOGY INTERNATIONAL, 2022, 16 (05) : 1170 - 1178
  • [4] Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study
    Welland, Sabrina
    Leyh, Catherine
    Finkelmeier, Fabian
    Jefremow, Andre
    Shmanko, Kateryna
    Gonzalez-Carmona, Maria A.
    Kandulski, Arne
    Jeliazkova, Petia
    Best, Jan
    Fruendt, Thorben W.
    Djanani, Angela
    Pangerl, Maria
    Maieron, Andreas
    Greil, Richard
    Fricke, Christina
    Sookthai, Disorn
    Guenther, Rainer
    Schmiderer, Andreas
    Wege, Henning
    Venerito, Marino
    Ehmer, Ursula
    Mueller, Martina
    Strassburg, Christian P.
    Weinmann, Arndt
    Siebler, Jurgen
    Waidmann, Oliver
    Lange, Christian M.
    Saborowski, Anna
    Vogel, Arndt
    [J]. LIVER CANCER, 2022, 11 (03) : 219 - 232
  • [5] Risk factors for hepatic encephalopathy in hepatocellular carcinoma after sorafenib or lenvatinib treatment: a real-world study
    Chen, Bowen
    Zhang, Linzhi
    Cheng, Jiamin
    Yang, Xu
    Lei, Jin
    Wu, Tong
    Yan, Tao
    Li, Yinyin
    Lu, Yinying
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S388 - S388
  • [6] Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World Study
    Chen, Bowen
    Zhang, Linzhi
    Cheng, Jiamin
    Wu, Tong
    Lei, Jin
    Yang, Xu
    Zhang, Rongling
    Safadi, Rifaat
    Li, Yinyin
    Si, Tongguo
    Lu, Yinying
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 4429 - 4437
  • [7] Efficacy and safety of lenvatinib monotreatment and lenvatinib-based combination therapy for patients with unresectable hepatocellular carcinoma: a retrospective, real-world study in China
    Zhu, Yun
    Sun, Penghui
    Wang, Kunyuan
    Xiao, Shuzhe
    Cheng, Yanling
    Li, Xiangzhao
    Wang, Biao
    Li, Jiancong
    Yu, Wenxuan
    Cheng, Yang
    [J]. CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [8] Efficacy and safety of lenvatinib monotreatment and lenvatinib-based combination therapy for patients with unresectable hepatocellular carcinoma: a retrospective, real-world study in China
    Yun Zhu
    Penghui Sun
    Kunyuan Wang
    Shuzhe Xiao
    Yanling Cheng
    Xiangzhao Li
    Biao Wang
    Jiancong Li
    Wenxuan Yu
    Yang Cheng
    [J]. Cancer Cell International, 21
  • [9] Real-World Effectiveness of Lenvatinib in Hepatocellular Carcinoma Patients with Nonalcoholic Steatohepatitis
    Singal, Amit G.
    Nagar, Saurabh P.
    Hitchens, Abby
    Davis, Keith L.
    Iyer, Shrividya
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (03)
  • [10] Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study
    Qu, Wei-Feng
    Ding, Zhen-Bin
    Qu, Xu-Dong
    Tang, Zheng
    Zhu, Gui-Qi
    Fu, Xiu-Tao
    Zhang, Zi-Han
    Zhang, Xin
    Huang, Ao
    Tang, Min
    Tian, Meng-Xin
    Jiang, Xi-Fei
    Huang, Run
    Tao, Chen-Yang
    Fang, Yuan
    Gao, Jun
    Wu, Xiao-Ling
    Zhou, Jian
    Fan, Jia
    Liu, Wei-Ren
    Shi, Ying-Hong
    [J]. BJS OPEN, 2022, 6 (05):
12345